mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
-0.18 |
0.2 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |